In this interview, News Medical speaks with Olivier Negre, Chief Scientific Officer at Smart Immune, about how immunotherapy is being revolutionized.

DiaMedica Therapeutics Inc.’s DMAC share price has dipped by 13.02%, which has investors questioning if this is right time to buy.

Barclays 27th Annual Global Healthcare Conference March 11, 2025 1:30 PM ETCompany ParticipantsRose Loughlin - EVP of ...

Using an unbiased approach, this important study discovered a role of Ezh2 in the differentiation of granule neuron precursors, the cell of origin for Shh group of medulloblastoma. Furthermore, the ...

Mayo Clinic launched a new prion test, RT-QuIC Prion, CSF, which can distinguish prion disease from other causes of rapidly ...

An interim appearance has been scheduled before a hearing panel of the Canadian Investment Regulatory Organization (CIRO) pursuant to the Mutual Fund Dealer Rules to address procedural matters in the ...

The combination adjuvant with spike protein antigen elicited robust responses to SARS ... described above to give a luminescence reading of ≥20,000 RLU/well above background in infected cells. Serum ...

The Max Planck Institute for Terrestrial Microbiology in Marburg is excited to offer three PhD positions in computational protein design. Hosted by the Bunzel group (Enzyme Design and Evolution), ...

Looking for the best protein powder? Our guide highlights the top picks for weight loss, women, budget, and more, tested and ...

Using single-cell RNA sequencing, we mapped thousands of expression quantitative trait loci in yeast, including a variant in GPA1 that influences gene expression, cell-cycle occupancy, and mating ...